Politics and Policy

A new report highlights the highest uninsured rates by state. Is your state among the top 10?

Healthcare industry leaders and policy analysts discuss how the election results could impact healthcare.

As part of efforts to combat the opioid epidemic, Cigna removes prior authorization from medication-assisted treatment for opioid use disorder.

A recent survey suggests suggest a lack of access to appropriate commercial payer arrangements is causing health systems to explore alternatives.

A new cancer database, the Genomic Data Commons, aims to make research more accessible

We asked executives how they feel about the future of healthcare. Here’s what they said.

With the presidential election quickly approaching, here’s your chance to know where your peers stand on key issues.

A new Commonwealth Fund study explores cost-sharing reduction plans and marketplace coverage.

It’s time for stakeholders to cooperate in order to limit the wasted spending on prescription medications and chart a path to collectively improving value derivation.

It’s time to step back and assess how the election could impact the managed care industry.

In April CMS released final rules outlining significant updates to the Medicaid managed care program. Here are the top issues to watch.

What is the future of Healthcare Exchanges? And what is the future of Obamacare in general? Healthcare executives weigh in.

While healthcare has flown under the radar for much of this election season, it’s a topic that was not ignored at the Academy of Managed Care Pharmacy (AMCP) Nexus in National Harbor, Maryland.

Approvals of specialty pharmaceuticals have far outpaced traditional drugs, and that trend will continue. But that’s not the only specialty medication trend that healthcare executives should have on their radar.

Understanding both candidates proposals can help executives make informed decisions.

Here are the top 10 states that deliver the best healthcare services, according to personal-finance website WalletHub.

Five key areas of healthcare, the candidates’ proposals for them, and analysis from experts.

The use of advanced analytics by payers can improve administrative and medicalcosts, provider satisfaction and member health.

Find out where each presidential candidate stands on key issues related to pharmaceutical costs.

Early planning to craft a comprehensive real-world evidence generation strategy can help support the real-world safety and effectiveness of biosimilars.

The proposed HHS Notice of Benefit and Payment Parameters for 2018 indicates CMS is focusing on refining the risk adjustment model to better compensate plans.

CMS’ Quality Payment Program (QPP) introduced in the Medicare Access and CHIP Reauthorization Act (MACRA) has created a seismic effect across provider organizations.

Managed Healthcare Executive conducted its first-ever managed care pharmacy survey during the second quarter of 2016 in partnership with Access Market Intelligence. Here’s a look at some of the key findings, with experts weighing in on the results.

Here’s what to expect from Blue Shield of California’s four-day closure over Obamacare losses.

As Aetna bows out of health insurance exchanges, more questions about viability are cropping up. Find out which other plans are exiting the health insurance exchanges.